EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 33 filers reported holding EVOKE PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,000 | – | 1,604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 175,000 | $448,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $1,280,000 | 0.22% |
| PRECEPT MANAGEMENT LLC | 95,000 | $243,000 | 0.15% |
| Family Management Corp | 10,425 | $27,000 | 0.02% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 400,000 | $1,024,000 | 0.01% |
| Acrospire Investment Management LLC | 2,489 | $6,000 | 0.01% |
| A.R.T. Advisors, LLC | 15,413 | $39,000 | 0.00% |
| NORTHERN TRUST CORP | 29,214 | $75,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 23,048 | $59,000 | 0.00% |
| DEUTSCHE BANK AG\ | 200 | $0 | 0.00% |